CALZA, LEONARDO
CALZA, LEONARDO
DIPARTIMENTO DI SCIENZE MEDICHE E CHIRURGICHE
Docenti di ruolo di IIa fascia
Improvement in insulin sensitivity after switching from an integrase inhibitor-based regimen to doravirine/tenofovir disoproxil fumarate/lamivudine in people with significant weight gain.
2024 Calza L, Giglia M, Colangeli V, Bon I, Vitale S, Viale P.
Risk of Cardiovascular Events in People with HIV (PWH) Treated with Integrase Strand-Transfer Inhibitors: The Debate Is Not Over; Results of the SCOLTA Study.
2024 Corti N, Menzaghi B, Orofino G, Guastavigna M, Lagi F, Di Biagio A, Taramasso L, De Socio GV, Molteni C, Madeddu G, Salomoni E, Pellicanò GF, Pontali E, Bellagamba R, Celesia BM, Cascio A, Sarchi E, Gulminetti R, Calza L, Maggi P, Cenderello G, Bandera A, Carleo MA, Falasca K, Ferrara S, Martini S, Guadagnino G, Angioni G, Bargiacchi O, Ricci ED, Squillace N, Bonfanti P.
Doravirine/lamivudine/tenofovir disoproxil fumarate in virologically suppressed people living with HIV: A real-life experience.
2023 Calza L, Colangeli V, Pensalfine G, Appolloni L, Vitale S, Bon I, Viale P
Lipids and Transaminase in Antiretroviral-Treatment-Experienced People Living with HIV, Switching to a Doravirine-Based vs. a Rilpivirine-Based Regimen: Data from a Real-Life Setting.
2023 Maggi P, Ricci ED, Martinelli CV, De Socio GV, Squillace N, Molteni C, Masiello A, Orofino G, Menzaghi B, Bellagamba R, Vichi F, Celesia BM, Madeddu G, Pellicanò GF, Carleo MA, Cascio A, Parisini A, Taramasso L, Valsecchi L, Calza L, Rusconi S, Sarchi E, Martini S, Bargiacchi O, Falasca K, Cenderello G, Ferrara S, Di Biagio A, Bonfanti P
Changes in Serum Inflammatory Markers in Antiretroviral Therapy-Naive HIV-Infected Patients Starting Dolutegravir/Lamivudine or Dolutegravir/Lamivudine/Abacavir
2022 Calza L, Legnani G, Fulgaro C, Verucchi G, Bon I, Lazzarotto T, Viale P
Changes in Serum Inflammatory Markers in Antiretroviral Therapy-Naive HIV-Infected Patients Starting Dolutegravir/Lamivudine or Tenofovir Alafenamide/Emtricitabine/Bictegravir
2022 Calza L, Bon I, Pensalfine G, Vitale S, Appolloni L, Viale P
Exosomes of mesenchymal stem cells delivered from methacrylated hyaluronic acid patch improve the regenerative properties of endothelial and dermal cells
2022 Ferroni, L; Gardin, C; D'Amora, U; Calza, L; Ronca, A; Tremoli, E; Ambrosio, L; Zavan, B
Growing old with antiretroviral therapy or elderly people in antiretroviral therapy: two different profiles of comorbidity?
2022 Maggi P, De Socio GV, Menzaghi B, Molteni C, Squillace N, Taramasso L, Guastavigna M, Gamboni G, Madeddu G, Vichi F, Cascio A, Sarchi E, Pellicanò G, Martinelli CV, Celesia BM, Valsecchi L, Gulminetti R, Cenderello G, Parisini A, Calza L, Falasca K, Orofino G, Ricci E, Di Biagio A, Bonfanti P.
Pattern of arterial inflammation and inflammatory markers in people living with HIV compared with uninfected people
2022 Taglieri, Nevio; Bonfiglioli, Rachele; Bon, Isabella; Malosso, Pietro; Corovic, Andrej; Bruno, Matteo; Le, Elizabeth; Granozzi, Bianca; Palmerini, Tullio; Ghetti, Gabriele; Tamburello, Martina; Bruno, Antonio Giulio; Saia, Francesco; Tarkin, Jason M.; Rudd, James H. F.; Calza, Leonardo; Fanti, Stefano; Re, Maria Carla; Galié, Nazzareno
Viral resistance burden and APOBEC editing correlate with virological response in heavily treatment-experienced people living with multi-drug resistant HIV.
2022 Armenia D, Santoro MM, Bellocchi MC, Carioti L, Galli L, Galli A, Scutari R, Salsi E, Mussini C, Sterrantino G, Calza L, Rossetti B, Zazzi M, Castagna A
Weight gain in treatment-naive HIV-1 infected patients starting abacavir/lamivudine/dolutegravir or tenofovir alafenamide/emtricitabine/bictegravir
2022 Calza L, Borderi M, Colangeli V, Miani T, Nuti B, Bon I, Lazzarotto T, Viale P
COVID-19 in patients with HIV-1 infection: a single-centre experience in northern Italy
2021 Calza L.; Bon I.; Tadolini M.; Borderi M.; Colangeli V.; Badia L.; Verucchi G.; Rossini G.; Vocale C.; Gaibani P.; Viale P.; Attard L.
COVID-19 Outcomes in Patients With Uncontrolled HIV-1 Infection.
2021 Calza L, Bon I, Borderi M, Colangeli V, Borioni A, Re MC, Viale P
Durability of Dolutegravir-Based Regimens: A 5-Year Prospective Observational Study.
2021 Taramasso L, De Vito A, Ricci ED, Orofino G, Squillace N, Menzaghi B, Molteni C, Gulminetti R, De Socio GV, Pellicanò GF, Sarchi E, Celesia BM, Calza L, Rusconi S, Valsecchi L, Martinelli CV, Cascio A, Maggi P, Vichi F, Angioni G, Guadagnino G, Cenderello G, Dentone C, Bandera A, Falasca K, Bonfanti P, Di Biagio A, Madeddu G
Novel understanding on genetic mechanisms of enteric neuropathies leading to severe gut dysmotility
2021 Bianco F.; Lattanzio G.; Lorenzini L.; Diquigiovanni C.; Mazzoni M.; Clavenzani P.; Calza L.; Giardino L.; Sternini C.; Bonora E.; De Giorgio R.
Restriction Factors expression decreases in HIV-1 patients after cART
2021 D'Urbano, Vanessa; Bertoldi, Alessia; Re, Maria Carla; De Crignis, Elisa; Tamburello, Martina; Primavera, Alessandra; Laginestra, Maria Antonella; Zanasi, Nicolò; Calza, Leonardo; Viale, Pier Luigi; Lazzarotto, Tiziana; Bon, Isabella; Gallinella, Giorgio
Rosuvastatin decreases serum inflammatory markers and slows atherosclerosis progression rate in treated HIV-infected patients with metabolic syndrome.
2021 Calza L, Colangeli V, Borderi M, Beci G, Esposito F, Bon I, Re MC, Viale P
Short Communication: No Significant Changes in Weight and Body Fat Mass in Suppressed HIV-Infected Patients Switched to Dual Combination Lamivudine Plus Dolutegravir or Raltegravir.
2021 Calza L, Borderi M, Colangeli V, Testi D, Amedeo A, Bon I, Re MC, Viale P
Short Communication: No Significant Increase in Body Fat Mass in Naive HIV-Infected Patients Starting Raltegravir Plus Tenofovir Disoproxil Fumarate/Emtricitabine.
2021 Calza L, Borderi M, Colangeli V, Esposito F, Giglia M, Bon I, Re MC
Development of C-TILDA: A modified TILDA method for reservoir quantification in long term treated patients infected with subtype C HIV-1
2020 Bertoldi A.; D'Urbano V.; Bon I.; Verbon A.; Rokx C.; Boucher C.; van Kampen J.J.A.; Gruters R.A.; Gallinella G.; Calza L.; Mahmoudi T.; De Crignis E.; Re M.C.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Improvement in insulin sensitivity after switching from an integrase inhibitor-based regimen to doravirine/tenofovir disoproxil fumarate/lamivudine in people with significant weight gain. | Calza L, Giglia M, Colangeli V, Bon I, Vitale S, Viale P. | 2024-01-01 | HIV MEDICINE | - | 1.01 Articolo in rivista | - |
| Risk of Cardiovascular Events in People with HIV (PWH) Treated with Integrase Strand-Transfer Inhibitors: The Debate Is Not Over; Results of the SCOLTA Study. | Corti N, Menzaghi B, Orofino G, Guastavigna M, Lagi F, Di Biagio A, Taramasso L, De Socio GV, Mol...teni C, Madeddu G, Salomoni E, Pellicanò GF, Pontali E, Bellagamba R, Celesia BM, Cascio A, Sarchi E, Gulminetti R, Calza L, Maggi P, Cenderello G, Bandera A, Carleo MA, Falasca K, Ferrara S, Martini S, Guadagnino G, Angioni G, Bargiacchi O, Ricci ED, Squillace N, Bonfanti P. | 2024-01-01 | VIRUSES | - | 1.01 Articolo in rivista | Viruses 2024.pdf |
| Doravirine/lamivudine/tenofovir disoproxil fumarate in virologically suppressed people living with HIV: A real-life experience. | Calza L, Colangeli V, Pensalfine G, Appolloni L, Vitale S, Bon I, Viale P | 2023-01-01 | INTERNATIONAL JOURNAL OF STD & AIDS | - | 1.01 Articolo in rivista | - |
| Lipids and Transaminase in Antiretroviral-Treatment-Experienced People Living with HIV, Switching to a Doravirine-Based vs. a Rilpivirine-Based Regimen: Data from a Real-Life Setting. | Maggi P, Ricci ED, Martinelli CV, De Socio GV, Squillace N, Molteni C, Masiello A, Orofino G, Men...zaghi B, Bellagamba R, Vichi F, Celesia BM, Madeddu G, Pellicanò GF, Carleo MA, Cascio A, Parisini A, Taramasso L, Valsecchi L, Calza L, Rusconi S, Sarchi E, Martini S, Bargiacchi O, Falasca K, Cenderello G, Ferrara S, Di Biagio A, Bonfanti P | 2023-01-01 | VIRUSES | - | 1.01 Articolo in rivista | Maggi_2023.pdf; viruses-15-01612-s001.zip |
| Changes in Serum Inflammatory Markers in Antiretroviral Therapy-Naive HIV-Infected Patients Starting Dolutegravir/Lamivudine or Dolutegravir/Lamivudine/Abacavir | Calza L, Legnani G, Fulgaro C, Verucchi G, Bon I, Lazzarotto T, Viale P | 2022-01-01 | JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES | - | 1.01 Articolo in rivista | AIDS 2022.pdf |
| Changes in Serum Inflammatory Markers in Antiretroviral Therapy-Naive HIV-Infected Patients Starting Dolutegravir/Lamivudine or Tenofovir Alafenamide/Emtricitabine/Bictegravir | Calza L, Bon I, Pensalfine G, Vitale S, Appolloni L, Viale P | 2022-01-01 | JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES | - | 1.01 Articolo in rivista | - |
| Exosomes of mesenchymal stem cells delivered from methacrylated hyaluronic acid patch improve the regenerative properties of endothelial and dermal cells | Ferroni, L; Gardin, C; D'Amora, U; Calza, L; Ronca, A; Tremoli, E; Ambrosio, L; Zavan, B | 2022-01-01 | BIOMATERIALS ADVANCES | - | 1.01 Articolo in rivista | - |
| Growing old with antiretroviral therapy or elderly people in antiretroviral therapy: two different profiles of comorbidity? | Maggi P, De Socio GV, Menzaghi B, Molteni C, Squillace N, Taramasso L, Guastavigna M, Gamboni G, ...Madeddu G, Vichi F, Cascio A, Sarchi E, Pellicanò G, Martinelli CV, Celesia BM, Valsecchi L, Gulminetti R, Cenderello G, Parisini A, Calza L, Falasca K, Orofino G, Ricci E, Di Biagio A, Bonfanti P. | 2022-01-01 | BMC INFECTIOUS DISEASES | - | 1.01 Articolo in rivista | BMC Infect Dis 2022.pdf; 12879_2022_7739_MOESM1_ESM.docx |
| Pattern of arterial inflammation and inflammatory markers in people living with HIV compared with uninfected people | Taglieri, Nevio; Bonfiglioli, Rachele; Bon, Isabella; Malosso, Pietro; Corovic, Andrej; Bruno, Ma...tteo; Le, Elizabeth; Granozzi, Bianca; Palmerini, Tullio; Ghetti, Gabriele; Tamburello, Martina; Bruno, Antonio Giulio; Saia, Francesco; Tarkin, Jason M.; Rudd, James H. F.; Calza, Leonardo; Fanti, Stefano; Re, Maria Carla; Galié, Nazzareno | 2022-01-01 | JOURNAL OF NUCLEAR CARDIOLOGY | - | 1.01 Articolo in rivista | 12350_2020_2522_MOESM1_ESM.docx; 12350_2020_2522_MOESM2_ESM.pptx; s12350-020-02522-5.pdf |
| Viral resistance burden and APOBEC editing correlate with virological response in heavily treatment-experienced people living with multi-drug resistant HIV. | Armenia D, Santoro MM, Bellocchi MC, Carioti L, Galli L, Galli A, Scutari R, Salsi E, Mussini C, ...Sterrantino G, Calza L, Rossetti B, Zazzi M, Castagna A | 2022-01-01 | INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS | - | 1.01 Articolo in rivista | Int J Antimicrob Ag 2022.pdf |
| Weight gain in treatment-naive HIV-1 infected patients starting abacavir/lamivudine/dolutegravir or tenofovir alafenamide/emtricitabine/bictegravir | Calza L, Borderi M, Colangeli V, Miani T, Nuti B, Bon I, Lazzarotto T, Viale P | 2022-01-01 | AIDS | - | 1.01 Articolo in rivista | - |
| COVID-19 in patients with HIV-1 infection: a single-centre experience in northern Italy | Calza L.; Bon I.; Tadolini M.; Borderi M.; Colangeli V.; Badia L.; Verucchi G.; Rossini G.; Vocal...e C.; Gaibani P.; Viale P.; Attard L. | 2021-01-01 | INFECTION | - | 1.01 Articolo in rivista | Infection 2021.pdf |
| COVID-19 Outcomes in Patients With Uncontrolled HIV-1 Infection. | Calza L, Bon I, Borderi M, Colangeli V, Borioni A, Re MC, Viale P | 2021-01-01 | JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES | - | 1.01 Articolo in rivista | - |
| Durability of Dolutegravir-Based Regimens: A 5-Year Prospective Observational Study. | Taramasso L, De Vito A, Ricci ED, Orofino G, Squillace N, Menzaghi B, Molteni C, Gulminetti R, De... Socio GV, Pellicanò GF, Sarchi E, Celesia BM, Calza L, Rusconi S, Valsecchi L, Martinelli CV, Cascio A, Maggi P, Vichi F, Angioni G, Guadagnino G, Cenderello G, Dentone C, Bandera A, Falasca K, Bonfanti P, Di Biagio A, Madeddu G | 2021-01-01 | AIDS PATIENT CARE AND STDS | - | 1.01 Articolo in rivista | - |
| Novel understanding on genetic mechanisms of enteric neuropathies leading to severe gut dysmotility | Bianco F.; Lattanzio G.; Lorenzini L.; Diquigiovanni C.; Mazzoni M.; Clavenzani P.; Calza L.; Gia...rdino L.; Sternini C.; Bonora E.; De Giorgio R. | 2021-01-01 | EUROPEAN JOURNAL OF HISTOCHEMISTRY | - | 1.01 Articolo in rivista | ejh-65-s1-3289 (1).pdf |
| Restriction Factors expression decreases in HIV-1 patients after cART | D'Urbano, Vanessa; Bertoldi, Alessia; Re, Maria Carla; De Crignis, Elisa; Tamburello, Martina; Pr...imavera, Alessandra; Laginestra, Maria Antonella; Zanasi, Nicolò; Calza, Leonardo; Viale, Pier Luigi; Lazzarotto, Tiziana; Bon, Isabella; Gallinella, Giorgio | 2021-01-01 | NEW MICROBIOLOGICA | - | 1.01 Articolo in rivista | NewMicrobiologica D'Urbano 2021.pdf |
| Rosuvastatin decreases serum inflammatory markers and slows atherosclerosis progression rate in treated HIV-infected patients with metabolic syndrome. | Calza L, Colangeli V, Borderi M, Beci G, Esposito F, Bon I, Re MC, Viale P | 2021-01-01 | INFECTIOUS DISEASES | - | 1.01 Articolo in rivista | - |
| Short Communication: No Significant Changes in Weight and Body Fat Mass in Suppressed HIV-Infected Patients Switched to Dual Combination Lamivudine Plus Dolutegravir or Raltegravir. | Calza L, Borderi M, Colangeli V, Testi D, Amedeo A, Bon I, Re MC, Viale P | 2021-01-01 | AIDS RESEARCH AND HUMAN RETROVIRUSES | - | 1.01 Articolo in rivista | - |
| Short Communication: No Significant Increase in Body Fat Mass in Naive HIV-Infected Patients Starting Raltegravir Plus Tenofovir Disoproxil Fumarate/Emtricitabine. | Calza L, Borderi M, Colangeli V, Esposito F, Giglia M, Bon I, Re MC | 2021-01-01 | AIDS RESEARCH AND HUMAN RETROVIRUSES | - | 1.01 Articolo in rivista | - |
| Development of C-TILDA: A modified TILDA method for reservoir quantification in long term treated patients infected with subtype C HIV-1 | Bertoldi A.; D'Urbano V.; Bon I.; Verbon A.; Rokx C.; Boucher C.; van Kampen J.J.A.; Gruters R.A....; Gallinella G.; Calza L.; Mahmoudi T.; De Crignis E.; Re M.C. | 2020-01-01 | JOURNAL OF VIROLOGICAL METHODS | - | 1.01 Articolo in rivista | Bertoldi et al. 2020.pdf |